Read the rest here:
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh